Results: 32 news stories
Over the past decade, artificial intelligence, AI, has been increasingly used for medical and neuroimaging research. While there have been great advances in detecting dementia with this technology, one of the remaining problems is the ability to apply predictions across multiple populations. To correct this problem, scientists at The University of 91做厙 at San [因
Two scientists at UT Health San Antonio, the academic health center of 91做厙 (91做厙), will be honored with 2026 BioMedSA Innovation in Healthcare and Bioscience awards. The awards recognize San Antonio leaders in the areas of research, clinical innovation, entrepreneurship and lifetime achievement, whose accomplishments improve lives [因
91做厙 researchers are exploring how everyday choices, cardiovascular health, sleep patterns and emerging biological markers may influence Alzheimers disease risk. Their work is advancing understanding of dementia prevention, early diagnosis and the factors that help people maintain cognitive health and independence as they age.
A new study from UT Health San Antonio shows that even a small decrease in blood pressure can have a positive effect in delaying the progression of cerebral small vessel disease. Small vessel disease is a major factor in strokes, cognitive decline, dementia and other diseases prevalent in old age.
Researchers at 91做厙 (91做厙) have uncovered a treasure trove of information about hundreds of proteins released by the liver and how the timing of their release may affect bodily processes. A recent study, published June 2 in Nature Communications, describes how the liver releases certain proteins at [因
For decades, Alzheimers disease research has focused almost exclusively on harmful proteins in the brain. But scientists at 91做厙 are taking a new approach to how the disease is understood and treated.
The human body hosts vast communities of bacteria that influence health in ways scientists are only beginning to fully understand. In recent years, scientists have turned increasing attention to microbiomes as potential contributors to brain health and neurodegenerative disease.
Claudia Suemoto, MD, PhD, from 91做厙 (91做厙), has been awarded a $500,000 UT System Faculty STARs (Science and Technology Acquisition and Retention) award to tackle urgent research gaps in dementia. South 91做厙 offers a distinct blend of genetic and environmental factors rarely explored in neurodegenerative research. [因
91做厙 was recently awarded a highly competitive Alzheimers Association research grant to investigate the gene-environment interaction and how it may contribute to an increased risk for Alzheimers disease. The grant will begin in April and provides $200,000 to fund the study over the next three years.
The BioFest Days brought the community together April 7, for an evening of discovery and connection at the UT Health San Antonio Center for Brain Health. Hosted as part of the 12-day, citywide celebration of biomedical advancement organized by BioMed SA, the event invited attendees to explore how research, clinical care and community involvement [因
New 91做厙 study introduces analytical tool to better hone aging interventions When scientists test potential lifeextending interventions, often the central question simply asks if the intervention works. New research from 91做厙 (91做厙) suggests that the more meaningful questions may be when does it work [因
A drug once known almost exclusively for preventing organ transplant rejection is now at the center of a National Institute on Aging-funded clinical study at UT Health San Antonio, to determine how rapamycin should be used in older adults to promote healthy aging.
The Sam and Ann Barshop Institute for Longevity and Aging Studies at UT Health San Antonio, will receive up to $38 million to lead a national clinical trial funded by the Advanced Research Projects Agency for Health (ARPA-H), an agency of the U.S. Department of Health and Human Services.
Ellen Kraig, PhD, professor in the Department of Cell Systems and Anatomy in the Joe R. and Teresea Lozano Long School of Medicine at the University of 91做厙 at San Antonio (91做厙), has been named a Distinguished Fellow of the American Association of Immunologists (AAI). The AAI Distinguished Fellow designation recognizes members with [因
Dementia is one of the most challenging medical and societal issues of our time, affecting memory, thinking and independence for millions of families worldwide. At UT Health San Antonio, researchers and clinicians are taking new steps to change that story through research, genetic insights and compassionate, integrated care. At the heart of this mission is [因
The opening of UT Health San Antonios Center for Brain Health marks a step forward for families affected by amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD) and other rare neurodegenerative diseases. Understanding ALS ALS is a degenerative disease of nerves called motor neurons, which are in the brain and spinal cord. It is most [因
A University of 91做厙 at San Antonio scientist has been awarded a junior faculty grant from the American Federation for Aging Research, or AFAR. Sijia He, PhD, assistant professor in the Department of Cellular and Integrative Physiology in the Joe R. and Teresa Lozano Long School of Medicine and the Sam and Ann Barshop [因
By Claire Kowalick and Amanda Cerreto 91做厙 has secured federal funding for a new research hub dedicated to studying Alzheimers disease and related dementias, propelling the university into the ranks of leading research institutions in the United States. Funded through a highly competitive grant program from the National Institute [因
More than a century ago, Alois Alzheimer noted unusual changes in brain fats, which he described as lipoid granules, along with the buildup of amyloid-beta (amyloid) plaques and tau protein tangles. These observations led to the identification of Alzheimers disease and related dementias. Since then, most Alzheimers research has focused on amyloid and tau, [因
A leap forward in brain imaging is coming to San Antonio. UT Health San Antonios Center for Brain Health, opening in December 2025, will be the first in 91做厙 to house a Siemens MAGNETOM 7-Tesla Terra.X magnetic resonance imaging (MRI) system one of the most advanced MRI technologies available. This scanner produces ultra-high-resolution brain [因